Florent Morio
@florentmorio.bsky.social
Professor, Nantes University Hospital, France. FECMM. Mycoses, antifungal resistance, One Health. @CHUnantes @NantesUniv. Dad x2. Views my own.
Reposted by Florent Morio
Name changes for fungi of medical importance, 2022–2024 | Journal of Clinical Microbiology journals.asm.org/doi/10.1128/...
Name changes for fungi of medical importance, 2022–2024 | Journal of Clinical Microbiology
Since fungal identification methods based on examination of morphological and phenotypic
features are complicated by the astonishing diversity of organisms capable of causing
human infections especial...
journals.asm.org
September 6, 2025 at 1:59 AM
Name changes for fungi of medical importance, 2022–2024 | Journal of Clinical Microbiology journals.asm.org/doi/10.1128/...
Reposted by Florent Morio
Small pangenome of Candida parapsilosis reflects overall low intraspecific diversity https://www.biorxiv.org/content/10.1101/2025.04.30.651475v1
May 1, 2025 at 1:34 PM
Small pangenome of Candida parapsilosis reflects overall low intraspecific diversity https://www.biorxiv.org/content/10.1101/2025.04.30.651475v1
Reposted by Florent Morio
Small pangenome of Candida parapsilosis reflects overall low intraspecific diversity https://www.biorxiv.org/content/10.1101/2025.04.30.651475v1
May 2, 2025 at 1:37 AM
Small pangenome of Candida parapsilosis reflects overall low intraspecific diversity https://www.biorxiv.org/content/10.1101/2025.04.30.651475v1
Reposted by Florent Morio
Candida parapsilosis and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel?
Roya Vahedi-Shahandashti, et al.
Antimicrobial Agents and Chemotherapy, 2025
doi.org/10.1128/aac....
Roya Vahedi-Shahandashti, et al.
Antimicrobial Agents and Chemotherapy, 2025
doi.org/10.1128/aac....
Candida parapsilosis and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel? | Antimicrobial Agents and Chemotherapy
Candidemia remains a prevalent and life-threatening infection, leading to considerable
morbidity and mortality, particularly in critically ill patients (1, 2). Invasive candidiasis affects over 250,00...
doi.org
July 1, 2025 at 6:23 PM
Candida parapsilosis and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel?
Roya Vahedi-Shahandashti, et al.
Antimicrobial Agents and Chemotherapy, 2025
doi.org/10.1128/aac....
Roya Vahedi-Shahandashti, et al.
Antimicrobial Agents and Chemotherapy, 2025
doi.org/10.1128/aac....
Reposted by Florent Morio
Checkout this article I found at PLOS: dx.plos.org/10.1371/jour...
Myco-Ed: Mycological curriculum for education and discovery
Fungi are important and hyperdiverse organisms, yet chronically understudied. Most fungal clades have no reference genomes, impeding our understanding of their ecosystem functions and use as solutions...
dx.plos.org
July 25, 2025 at 1:08 AM
Checkout this article I found at PLOS: dx.plos.org/10.1371/jour...
Reposted by Florent Morio
Small pangenome of Candida parapsilosis reflects overall low intraspecific diversity https://www.biorxiv.org/content/10.1101/2025.04.30.651475v1
May 1, 2025 at 1:34 PM
Small pangenome of Candida parapsilosis reflects overall low intraspecific diversity https://www.biorxiv.org/content/10.1101/2025.04.30.651475v1
Reposted by Florent Morio
Excited to share that our story on S. aureus antagonism by Malassezia is live today in Current Biology! The paper has changed a lot since the preprint with the very exciting addition of having identified the antimicrobial effector generated by M. sympodialis.
authors.elsevier.com/c/1kwzj3QW8S...
authors.elsevier.com/c/1kwzj3QW8S...
authors.elsevier.com
April 14, 2025 at 5:33 PM
Excited to share that our story on S. aureus antagonism by Malassezia is live today in Current Biology! The paper has changed a lot since the preprint with the very exciting addition of having identified the antimicrobial effector generated by M. sympodialis.
authors.elsevier.com/c/1kwzj3QW8S...
authors.elsevier.com/c/1kwzj3QW8S...
Reposted by Florent Morio
ECMM Candida IV Study is still open for participation
Global study on non-albicans candidemia
Requirements:
🔬Clinical data + isolates (no limit per site)
📅Apr 2024-Sep 2025
📦Ship isolates in one batch at study end
💰Case-based reimbursement available
@martinhoenigl.bsky.social
Global study on non-albicans candidemia
Requirements:
🔬Clinical data + isolates (no limit per site)
📅Apr 2024-Sep 2025
📦Ship isolates in one batch at study end
💰Case-based reimbursement available
@martinhoenigl.bsky.social
April 8, 2025 at 6:59 AM
ECMM Candida IV Study is still open for participation
Global study on non-albicans candidemia
Requirements:
🔬Clinical data + isolates (no limit per site)
📅Apr 2024-Sep 2025
📦Ship isolates in one batch at study end
💰Case-based reimbursement available
@martinhoenigl.bsky.social
Global study on non-albicans candidemia
Requirements:
🔬Clinical data + isolates (no limit per site)
📅Apr 2024-Sep 2025
📦Ship isolates in one batch at study end
💰Case-based reimbursement available
@martinhoenigl.bsky.social
🆕️All you need to know about antifungal resistance in non fumigatus Aspergillus species. Great article led by Elie Djenontin and Eric Dannaoui. Glad to contribute 🙏
Just published in Mycoses
pubmed.ncbi.nlm.nih.gov/40219727/
Just published in Mycoses
pubmed.ncbi.nlm.nih.gov/40219727/
Antifungal Resistance in Non-fumigatus Aspergillus Species - PubMed
This review provides an in-depth exploration of antifungal resistance in non-fumigatus Aspergillus species, mainly focusing on acquired resistance. The available data have been compiled and sometimes ...
pubmed.ncbi.nlm.nih.gov
April 13, 2025 at 11:59 AM
🆕️All you need to know about antifungal resistance in non fumigatus Aspergillus species. Great article led by Elie Djenontin and Eric Dannaoui. Glad to contribute 🙏
Just published in Mycoses
pubmed.ncbi.nlm.nih.gov/40219727/
Just published in Mycoses
pubmed.ncbi.nlm.nih.gov/40219727/
Reposted by Florent Morio
WHO reports on the critical lack of medicines and diagnostic tools for invasive fungal diseases.
#PublicHealth
www.who.int/news/item/01...
#PublicHealth
www.who.int/news/item/01...
WHO issues its first-ever reports on tests and treatments for fungal infections
WHO's reports addressing the critical lack of medicines and diagnostic tools for invasive fungal diseases, shows urgent need for innovative research and development (R&D) to close the gaps. Fungal dis...
www.who.int
April 1, 2025 at 1:15 PM
WHO reports on the critical lack of medicines and diagnostic tools for invasive fungal diseases.
#PublicHealth
www.who.int/news/item/01...
#PublicHealth
www.who.int/news/item/01...
Reposted by Florent Morio
The organization's reports discuss the small number of newly approved treatments, the limited, late-stage antifungal pipeline, and challenges around diagnostics for this class of infections. #IDsky #Medsky
WHO Issues First Reports on Diagnostics, Therapies For Fungal Infections
The organization's reports discuss the small number of newly approved treatments, the limited, late-stage antifungal pipeline, and challenges around diagnostics for this class of infections.
www.contagionlive.com
April 1, 2025 at 4:31 PM
Reposted by Florent Morio
👉Participate in the ECMM Candida IV Study
🌍wide study on candidemia caused by non-albicans Candida
Requirement: clinical data & isolate (not req for C.auris)
Observation period: 04/2024 - 09/2025 Interested?
Email stella.wolfgruber@medunigraz.at
🌍wide study on candidemia caused by non-albicans Candida
Requirement: clinical data & isolate (not req for C.auris)
Observation period: 04/2024 - 09/2025 Interested?
Email stella.wolfgruber@medunigraz.at
April 2, 2025 at 11:08 AM
👉Participate in the ECMM Candida IV Study
🌍wide study on candidemia caused by non-albicans Candida
Requirement: clinical data & isolate (not req for C.auris)
Observation period: 04/2024 - 09/2025 Interested?
Email stella.wolfgruber@medunigraz.at
🌍wide study on candidemia caused by non-albicans Candida
Requirement: clinical data & isolate (not req for C.auris)
Observation period: 04/2024 - 09/2025 Interested?
Email stella.wolfgruber@medunigraz.at
Reposted by Florent Morio
Two journals tried paying peer reviewers and found increased acceptance, earlier reports, and no change in quality.
WHAT A SURPRISE!
WHAT A SURPRISE!
March 29, 2025 at 7:10 PM
Two journals tried paying peer reviewers and found increased acceptance, earlier reports, and no change in quality.
WHAT A SURPRISE!
WHAT A SURPRISE!
Thrilled to see our work featured on @ASMicrobiology's podcast, Best Papers of AAC 2024! 🎉🔬 Thanks to #AAC for the spotlight!
🎧 Listen to the podcast:
www.youtube.com/watch?v=gh0D...
📄 Read the paper: journals.asm.org/doi/10.1128/...
#UR1155 #NantesUniversité
🎧 Listen to the podcast:
www.youtube.com/watch?v=gh0D...
📄 Read the paper: journals.asm.org/doi/10.1128/...
#UR1155 #NantesUniversité
Best Papers of AAC, 2024 - Editors in Conversation AAC Edition
YouTube video by American Society for Microbiology
www.youtube.com
February 18, 2025 at 8:32 AM
Thrilled to see our work featured on @ASMicrobiology's podcast, Best Papers of AAC 2024! 🎉🔬 Thanks to #AAC for the spotlight!
🎧 Listen to the podcast:
www.youtube.com/watch?v=gh0D...
📄 Read the paper: journals.asm.org/doi/10.1128/...
#UR1155 #NantesUniversité
🎧 Listen to the podcast:
www.youtube.com/watch?v=gh0D...
📄 Read the paper: journals.asm.org/doi/10.1128/...
#UR1155 #NantesUniversité
Reposted by Florent Morio
Very interesting! Azole resistant #Candida auris in locusts. www.biorxiv.org/content/10.1...
South African brown locusts, Locustana pardalina, hosts fluconazole resistant Candidozyma (Candida) auris (Clade III)
The environmental niche and mode of transmission from the environment to humans of the emerging pathogenic yeast, Candidozyma ( Candida ) auris is a subject of speculation, with hypotheses including a...
www.biorxiv.org
February 12, 2025 at 4:20 AM
Very interesting! Azole resistant #Candida auris in locusts. www.biorxiv.org/content/10.1...
🚨 One more outbreak of FLC-R Candida parapsilosis described in the UK. @bramspr.bsky.social
pubmed.ncbi.nlm.nih.gov/39878027/
pubmed.ncbi.nlm.nih.gov/39878027/
Cluster of clonal fluconazole-resistant Candida parapsilosis harbouring Y132F mutation in ERG11 gene in a neonatal ICU in the UK - PubMed
Cluster of clonal fluconazole-resistant Candida parapsilosis harbouring Y132F mutation in ERG11 gene in a neonatal ICU in the UK
pubmed.ncbi.nlm.nih.gov
February 2, 2025 at 11:25 AM
🚨 One more outbreak of FLC-R Candida parapsilosis described in the UK. @bramspr.bsky.social
pubmed.ncbi.nlm.nih.gov/39878027/
pubmed.ncbi.nlm.nih.gov/39878027/
Reposted by Florent Morio
Health researchers alarmed as Trump admin pauses travel, communications
“Everything is basically in chaos. And frankly everyone is terrified. We’ve never seen anything like this. This is like a meteor just crashed into all of our cancer centers and research areas.”
Gift access: wapo.st/4jI1Wuj
“Everything is basically in chaos. And frankly everyone is terrified. We’ve never seen anything like this. This is like a meteor just crashed into all of our cancer centers and research areas.”
Gift access: wapo.st/4jI1Wuj
Health researchers alarmed as Trump administration pauses travel, communications
The halt has frozen research grants, meetings and key health updates. “Everything is basically in chaos,” said one cancer researcher.
wapo.st
January 23, 2025 at 10:21 PM
Health researchers alarmed as Trump admin pauses travel, communications
“Everything is basically in chaos. And frankly everyone is terrified. We’ve never seen anything like this. This is like a meteor just crashed into all of our cancer centers and research areas.”
Gift access: wapo.st/4jI1Wuj
“Everything is basically in chaos. And frankly everyone is terrified. We’ve never seen anything like this. This is like a meteor just crashed into all of our cancer centers and research areas.”
Gift access: wapo.st/4jI1Wuj
Reposted by Florent Morio
BREAKING: US health agency employees are now banned from nearly all travel and certain agencies and programs have been ordered to stop issuing new contracts and grants until further notice. www.theguardian.com/us-news/2025...
Travel, grant and funding cuts ‘stifling’ US health agencies in new Trump era
Halts to external communications, publishing reports and reviewing and approving research a ‘dramatic shift’
www.theguardian.com
January 24, 2025 at 2:52 PM
BREAKING: US health agency employees are now banned from nearly all travel and certain agencies and programs have been ordered to stop issuing new contracts and grants until further notice. www.theguardian.com/us-news/2025...
Reposted by Florent Morio
One of my friends has a grant from the #FDA to look at disparities in clinical trial research and just submitted a manuscript with the findings. She was told today by the collaborators from the #FDA to rescind it.
#Censorhip has started, we are living in authoritarian government.
#Censorhip has started, we are living in authoritarian government.
US FDA drops web pages on improving clinical trial diversity
The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and devices in diverse populations as part of a purge of diversity, equity and inclusion efforts at U.S. health agencies.
www.reuters.com
January 25, 2025 at 2:22 AM
One of my friends has a grant from the #FDA to look at disparities in clinical trial research and just submitted a manuscript with the findings. She was told today by the collaborators from the #FDA to rescind it.
#Censorhip has started, we are living in authoritarian government.
#Censorhip has started, we are living in authoritarian government.
Reposted by Florent Morio
Epidemiology and Prognostic Factors Associated With Mold-Positive Blood Cultures: 10-Year Data From a French Prospective Surveillance Program (2012–2022)
academic.oup.com/cid/advance-...
academic.oup.com/cid/advance-...
January 11, 2025 at 2:51 PM
Epidemiology and Prognostic Factors Associated With Mold-Positive Blood Cultures: 10-Year Data From a French Prospective Surveillance Program (2012–2022)
academic.oup.com/cid/advance-...
academic.oup.com/cid/advance-...
Reposted by Florent Morio
Enjoying presenting our work on European populations of the lager yeast parent Saccharomyces eubayanus in Coquimbo, Chile SOMICH. Thanks to @fcocubillosr.bsky.social
December 3, 2024 at 10:16 PM
Enjoying presenting our work on European populations of the lager yeast parent Saccharomyces eubayanus in Coquimbo, Chile SOMICH. Thanks to @fcocubillosr.bsky.social
Reposted by Florent Morio
Early deadline for ECFG17 fast approaching! Come to Dublin in Spring 2025.
December 4, 2024 at 2:16 PM
Early deadline for ECFG17 fast approaching! Come to Dublin in Spring 2025.
Reposted by Florent Morio
There is competitive #PhD funding for 4 years (eligibility criteria apply) to do a project on the human pathogen Candidozyma (Candida) auris dissecting the genetic basis of its antimicrobial resistance #AMR www.findaphd.com/phds/project... - pls repost
EASTBIO: Harnessing Transposon Mutagenesis to Dissect Antifungal Drug Resistance in the Fungal “Superbug” Candidozyma auris at University of Aberdeen on FindAPhD.com
PhD Project - EASTBIO: Harnessing Transposon Mutagenesis to Dissect Antifungal Drug Resistance in the Fungal “Superbug” Candidozyma auris at University of Aberdeen , listed on FindAPhD.com
www.findaphd.com
December 13, 2024 at 2:52 PM
There is competitive #PhD funding for 4 years (eligibility criteria apply) to do a project on the human pathogen Candidozyma (Candida) auris dissecting the genetic basis of its antimicrobial resistance #AMR www.findaphd.com/phds/project... - pls repost